Interleukin 6 polymorphisms as an indicator of COVID-19 severity in humans

Nikhil Kirtipala Department of Science, Modern Institute of Technology, Dhalwala, Rishikesh, Uttarakhand, India

Shiv Bharadwajb Department of Biotechnology, Institute of Biotechnology, College of Life and Applied Sciences, Yeungnam University, Gyeongsan, Gyeongbuk, Republic of KoreaCorrespondence[email protected]

https://orcid.org/0000-0003-2832-8617

Click to increase image sizeClick to decrease image size

Disclosure statement

Authors declares no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Interleukin 6 polymorphisms as an indicator of COVID-19 severity in humans

Information for

Open access

Opportunities

Help and information

Interleukin 6 polymorphisms as an indicator of COVID-19 severity in humans

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature